Keywords: Baxter, Celvapan, EC approval, H1N1 vaccine

EC final OK for Baxter’s H1N1 flu vaccine Celvapan

Article | 08 October 2009

Print This

The European Commission (EC) has granted marketing authorization for US drugmaker Baxter’s Celvapan H1N1 pandemic vaccine using Baxter’ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in